Pharma Industry
Industry: Email Alert RSS FeedTransgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test.
BIOTECH Patent News, February, 2009
Transgenomic, Inc. (Omaha, NE) and Power3 Medical Products, Inc. (Houston, TX) announced they have finalized a transaction, pursuant to their signed Letter of Intent announced December 2, 2008 (see "Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products' Neurodegenerative Diagnostics"), with the signing of a definitive collaboration and exclusive license agreement for the rights to Power3 Medical's neurodegenerative biomarkers.
The agreement grants Transgenomic exclusive rights in the United States and certain international markets to neurodegenerative biomarkers from Power3 Medical, including NuroPro, a proposed diagnostic for Alzheimer's and Parkinson's diseases based on Power3's proteomics...
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
Most Recent Technology Articles
- INTERVIEW WITH BEN BUTTERS, DIRECTOR OF EUROPEAN AFFAIRS AT EUROCHAMBRES : "A PERFECT ROAD MAP FOR EU CLUSTERS DOES NOT EXIST".
- AGENDA.(Brief article)(Conference notes)
- FIGHT AGAINST INTERNET PIRACY.
- INTERNET : AUTHORS' SOCIETIES URGE ACTION AGAINST PIRACY.
- TELECOMMUNICATIONS : BUSINESSEUROPE HOSTILE TO FURTHER CONTRACTUAL OBLIGATIONS.(Brief article)
Most Recent Technology Publications
Most Popular Technology Articles
- 3G: naughty or nice? PhoneErotica.com generates over 300 million hits per month, and rings up more minutes of use per month than MSN
- Business process re-engineering in the small firm: A case study
- Performance analysis of shell and tube heat exchanger using miscible system
- What is precision air conditioning and why is it necessary?
- Optimizing of Trichoderma viride cultivation in submerged state fermentation
